| Product Code: ETC11555598 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India central nervous disorders therapeutics market import shipment chart reflects a steady expansion from 2020 to 2024, with a notable CAGR of 6.5%. The growth rate surged by 60.5% between 2023 and 2024, indicating a significant momentum towards the end of the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Central Nervodisorders Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Central Nervodisorders Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Central Nervodisorders Therapeutics Market - Industry Life Cycle |
3.4 India Central Nervodisorders Therapeutics Market - Porter's Five Forces |
3.5 India Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Central Nervodisorders Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Central Nervodisorders Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of central nervous disorders in India |
4.2.2 Growing awareness about mental health and neurological conditions |
4.2.3 Advancements in healthcare infrastructure and technologies in India |
4.3 Market Restraints |
4.3.1 High cost of central nervous disorder therapeutics |
4.3.2 Limited access to healthcare services, especially in rural areas |
4.3.3 Regulatory challenges and approval processes for new therapeutics in India |
5 India Central Nervodisorders Therapeutics Market Trends |
6 India Central Nervodisorders Therapeutics Market, By Types |
6.1 India Central Nervodisorders Therapeutics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Neuroprotective Drugs, 2021 - 2031F |
6.1.4 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.5 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.1.6 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
6.2 India Central Nervodisorders Therapeutics Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Small Molecule Therapy, 2021 - 2031F |
6.2.3 India Central Nervodisorders Therapeutics Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.2.4 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Regenerative Medicine, 2021 - 2031F |
6.2.5 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Nanotechnology, 2021 - 2031F |
6.3 India Central Nervodisorders Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.4 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.5 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 India Central Nervodisorders Therapeutics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Treatment of Neurodegenerative Disorders, 2021 - 2031F |
6.4.3 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Genetic Disorder Correction, 2021 - 2031F |
6.4.4 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Neuron Regeneration, 2021 - 2031F |
6.4.5 India Central Nervodisorders Therapeutics Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
7 India Central Nervodisorders Therapeutics Market Import-Export Trade Statistics |
7.1 India Central Nervodisorders Therapeutics Market Export to Major Countries |
7.2 India Central Nervodisorders Therapeutics Market Imports from Major Countries |
8 India Central Nervodisorders Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials for central nervous disorder therapeutics in India |
8.2 Adoption rate of novel treatment approaches for central nervous disorders |
8.3 Number of healthcare facilities offering specialized care for central nervous disorders |
9 India Central Nervodisorders Therapeutics Market - Opportunity Assessment |
9.1 India Central Nervodisorders Therapeutics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Central Nervodisorders Therapeutics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Central Nervodisorders Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Central Nervodisorders Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Central Nervodisorders Therapeutics Market - Competitive Landscape |
10.1 India Central Nervodisorders Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Central Nervodisorders Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here